asco: tivozanib for metastatic renal cell carcinoma
Published 3 years ago • 162 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
12:49
the tivo-3 study of tivozanib in metastatic renal cell carcinoma
-
2:43
adverse effect profile for tivozanib plus sorafenib for relapsed/refractory renal cell carcinoma
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
2:42
latest from tivo-3: tivozanib for refractory advanced renal cell carcinoma
-
4:18
tivozanib for refractory advanced rcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
6:19
asco gu 2013: tivo 1 study shows tivozanib an option for renal cell carcinoma: dr robert motzer
-
0:59
data support use of tivozanib in patients with advanced renal cell carcinoma
-
1:57
dr. mayer on tivozanib in renal cell carcinoma and breast cancer
-
1:41
tivozanib tolerability shows potential advantage for patients with advanced rcc
-
1:15
tivozanib could evaluated in combination regimens for renal cell carcinoma
-
0:55
dr. hutson on tivozanib for renal cell carcinoma
-
2:06
dr. rini discusses tivozanib in advanced rcc
-
4:07
predictive biomarkers in metastatic renal cell carcinoma
-
9:21
updates on papillary renal cell carcinoma from asco gu 2018
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
1:44
highlights in renal cell carcinoma from asco gu 2023 and what to look out for in the future
-
20:39
kidney cancer conference highlights from asco gu 2023
-
9:06
precision medicine in metastatic renal cell carcinoma